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The primary function of the epidermis is to provide a protective barrier against numerous environmental insults,
including ultraviolet radiation (UVR). UVR, particularly in the UVB spectrum, is a potent carcinogen known to
damage DNA directly or through the generation of free radicals. Although in the long term, protective measures
such as apoptosis and inﬂammation may prove beneﬁcial in safeguarding the epidermis against the propagation of
potentially tumorigenic cells, after high-dose UV irradiation these biologic events may be acutely detrimental to the
architectural and functional integrity of the tissue owing to rampant cell death and inﬂammatory responses, which
can culminate in epidermal erosion and consequently loss of barrier functions. The mitogen-activated protein
kinase (MAPK) signaling pathway is known to be activated by UVR and herein we identify p38 MAPK as a key
modulator of these physiologic events. Mice treated with the p38 MAPK inhibitor SB202190 are protected against
several detrimental effects of acute UV irradiation, namely, sunburn cell/apoptosis, inﬂammation, and a
hyperproliferation response. Based on our results, selectively blocking p38 activation with the SB202190 inhibitor
could prove beneﬁcial in treating victims from severe sunburn or exposure to other chemical agents known to
trigger the p38 pathway.
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Ultraviolet radiation (UVR) is a potent damaging agent that
continuously challenges the epidermis. UVB radiation in
particular constitutes the major contributor to many adverse
cutaneous effects such as erythema, edema, blistering,
hyperplasia, and nonmelanoma skin cancer among others
(Afaq and Mukhtar, 2001). UVB radiation exposure is known
to induce a wide variety of cellular damage to epidermal
keratinocytes including DNA damage, oxidative stress, and
immunotoxicity (Sarasin, 1999; Cadet et al, 2001; Clydes-
dale et al, 2001; Wenk et al, 2001). UVB radiation will directly
and indirectly target the DNA, producing a variety of lesions,
such as cyclobutane pyrimidine dimers, pyrimidine-pyrimi-
done (6–4)photoproducts and oxidative DNA base damage,
which are believed to be the initiating steps in tumorigenesis
(Cadet et al, 2001). Therefore, substantial UVR expo-
sure may lead to detrimental acute effects such as tissue
damage owing in part to the organism’s surveillance
mechanism(s) attempting to eliminate damaged cells
through apoptosis and inflammation (Cadet et al, 2001;
Clydesdale et al, 2001).
A landmark discovery in the photobiology of the skin was
the finding that apoptosis after UVR requires the p53 tumor
suppressor pathway (Ziegler et al, 1994). As in human skin,
UVR of normal mouse skin rapidly triggers apoptosis of
keratinocytes, commonly referred to as ‘‘sunburn cells,’’
and a sunburn phenotype. In contrast, mice deficient in this
pathway, such as Trp53–/– (p53 knockout), show markedly
reduced apoptosis and sunburning response (Ziegler et al,
1994). p53’s ‘‘guardian’’ role in preventing tumorigenesis is
due in large part to its ability to regulate the expression of
multiple stress-inducible genes whose products are in-
volved in maintaining genomic integrity such as cell-cycle
regulation, DNA repair, and apoptosis (Amundson et al,
1998). Although the ATM pathway has a prominent role in
p53 activation after ionizing radiation, p53 activation after
UVR has important differences (Zhan et al, 1993; Bulavin
et al, 1999; Appella and Anderson, 2000) in that signaling is
typically not through ATM but rather other pathways such as
the mitogen-activated protein kinase (MAPK) signaling
pathway (Bulavin et al, 1999; Wang et al, 2000; Hildesheim
et al, 2002). In particular, the p38 portion of the MAPK
signaling pathway has been shown to have a major role in
p53 activation after UVR, particularly of its proapoptotic
functions (Bulavin et al, 1999; Takekawa et al, 2000).
Additionally, p53-effector gene products, such as Gadd45a,
have recently been found to be involved in a positive
feedback loop modulating p38 activity, and consequently
p53 activity, after UVR (Takekawa and Saito, 1998;
Takekawa et al, 2000; Hildesheim et al, 2002). As a result,
Gadd45a–/– mice are resistant to UVR-induced apoptosis/
sunburn cells owing to a large extent to a loss of sustained
Abbreviations: JNK, c-Jun N-terminal kinase; MAPK, mitogen-
activated protein kinase; TUNEL, terminal deoxynucleotidyl trans-
ferase dUTP nicked end-labeling; UVR, ultraviolet radiation.
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p38 MAPK activity, and the phenotype of UV-irradiated
Gadd45a–/– skin is remarkably similar to Trp53–/–.
Although p38- and p53-mediated apoptosis and inflam-
mation are critical in protecting the integrity of the epidermis
against the tumorigenic effects of UVR-induced damage,
acute UVR exposure may lead to tissue damage owing to
rampant apoptosis, inflammation, and necrosis (Clydesdale
et al, 2001). In this report, we have studied the effectiveness
of the p38a/b inhibitor SB202190 in blocking p38 and p53
activity and in doing so preventing the acute responses to
UVB irradiation leading to tissue erosion. We demonstrate
that SB202190 is able to significantly block acute UVR-
induced sunburn cells and subcorneal pustules. Our results
indicate that p38 MAPK inhibitors may have utility in the
management of acute solar injuries as well as injuries
resulting from many chemical damaging agents that trigger
the p38 MAPK pathway.
Results
p38 inhibitor blocks UVR-induced sunburn cells UVR-
damaged keratinocytes are genetically programmed to
undergo apoptosis at sufficiently high doses presumably
as a precaution against propagating potentially tumorigenic
cells (Hildesheim et al, 2002). Because p38 MAPK is known
to be activated by UVR and promote apoptosis via p53, we
sought to determine whether the p38a/b inhibitor SB202190
is able to block sunburn (apoptotic) cells from being
generated after an acute dose of UVB radiation (Hildesheim
et al, 2002). As shown in Fig 1, adult mice irradiated with
2000 Jm2 UVB radiation are able to effectively block
apoptosis when treated with this inhibitor. In stark contrast,
animals not treated with SB202190 develop appreciable
numbers of sunburn cells. Characteristic dyskeratotic
sunburn cells with pyknotic nuclei are readily detected by
histologic analysis (Fig 1a) and confirmed immunohisto-
chemically by performing the TUNEL assay (Fig 1b). The
TUNEL assay selectively detects nuclei with fragmented
DNA, a hallmark of apoptosis. Moreover, quantitative
analysis of the data (Fig 2) demonstrates that animals
treated with SB202190 have a 60% reduction in the number
of sunburn cells relative to untreated irradiated controls
(p¼ 0.016, Table I). A noticeable protective effect is also
observed in mice treated with SB202190 either 30 min (46%
reduction) or 120 min (23% reduction) after UVB irradiation,
although as noted, the effectiveness of the inhibitor in
blocking the generation of sunburn cells decreased with
increased delay in administration of the inhibitor (data not
shown). Unlike the dramatic inhibitory effects observed with
SB202190 on the irradiated groups, the treatment of the
unirradiated controls with the inhibitor had no significant
effect (p¼0.062). Therefore, blocking UVR-induced p38
activation significantly blocks epidermal keratinocytes from
an acute sunburn response.
UVR-induced sunburn cells are a result of p38 activation
and not JNK activation Although both p38 and JNK may
promote apoptosis after genotoxic stress (Robinson and
Cobb, 1997; Martin-Blanco, 2000), our results indicate that
sunburn cells emerge primarily as a result of p38 MAPK
activation and not JNK MAPK activation. Although p38
phosphorylation is not blocked by SB202190 (Fig 3a), its
activity is blocked by the inhibitor, which prevents p38 from
activating its downstream target p53. p38 activity (and
consequently p53 activity) is measured by the ability of
keratinocytes to express the p53-effector gene product,
p21, after UVR. Nuclear accumulation of p21 is only
detected in basal keratinocytes of UV-irradiated mice not
treated with the inhibitor (Fig 3c). This indicates that p53-
dependent transactivation of the p21 gene is inhibited due
to a block of p38 activity. In sharp contrast JNK MAPK
activation is not inhibited because both JNK (Fig 3b) and its
downstream target c-Jun (Fig 3d) are readily phosphory-
lated after UVR irrespective of the inhibitor. These results
not only demonstrate the specificity of the inhibitor but also
strongly implicate p38 MAPK as a primary inducer of
apoptosis in epidermal keratinocytes following acute UVR.
Figure1
Effects of the p38 inhibitor SB202190 on UVR-induced sunburn
cells. Adult mice were irradiated with 2000 Jm2 UVB, and the
exposed skin was harvested 24 h after UVR for histology/immunohis-
tochemistry after formalin fixation. (A) Hematoxylin and eosin staining
reveals that epidermal keratinocytes of SB202190-treated mice
(bottom right panel) are resistant to UVR-induced sunburn/apoptosis.
In sharp contrast, untreated, UV-irradiated mice (bottom left panel)
readily develop sunburn cells (arrows) with the characteristic dysker-
atotic cytoplasm and pyknotic nuclei. The epidermis from unirradiated
and SB202190-treated mice (top right panel) rarely develops apoptotic
cells and is indistinguishable from unirradiated and untreated controls
(top left panel). (B) TUNEL assay on the same tissues demonstrate the
same effect as above, whereby DNA fragmentation is widely detected
in epidermal keratinocytes of UV-irradiated mice not treated with the
inhibitor (arrows, bottom left panel). In contrast, irradiated SB202190-
treated mice (bottom right panel) are similar to unirradiated controls
(top panels). Representative images of experiments performed in
triplicate are shown (three animals per group). Scale bar, 20mm.
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UVR-induced inﬂammation and hyperproliferation are
blocked by the p38 inhibitor Additional detrimental
physiologic responses to acute UVR include inflammation
and epidermal hyperplasia (Clydesdale et al, 2001). Both of
these effects are dramatically reduced with the p38 inhibitor
treatment, irrespective of whether the inhibitor was admi-
nistered 30 min before or 120 min after UV irradiation
(data not shown). As shown histologically, irradiated mice
rapidly develop subcorneal pustules (Fig 4, panel v) that
are readily blocked by the p38 inhibitor (Fig 4, panel iv).
Moreover, SB202190-treated mice do not display a hyper-
proliferative reaction to UV irradiation and maintain a nor-
mal thickness epidermis comparable to unirradiated con-
trols (Fig 4, panels i, ii, and iv). In contrast, UV-irradiated
mice not treated with the inhibitor have a strong hyperpro-
liferative response and develop a significantly thicker and
more cellular epidermis (Fig 4, panel iii). Therefore, blocking
of p38 MAPK signaling with SB202190 mitigates the acute
responses and subsequent damage in the epidermis
enabling the skin to maintain its normal architectural
integrity.
Discussion
The epidermis is at the forefront of protection to the
organism against multiple environmental insults. One such
insult is UVR, which is considered to be a potent and
complete carcinogen causing the most common form of
cancers, nonmelanoma skin cancers (Quinn, 1997; Brash
and Ponten, 1998; Wikonkal and Brash, 1999). Keratino-
cytes are well equipped to protect the integrity of the
epidermis against the propagation of potentially cancerous
cells that may originate after chronic exposure to UVR. The
built-in responses to genotoxic stress include genetic
activation of programmed cell death, activation of an
inflammatory response to effectively eliminate damaged
cells, and eventual replacement of ill-fated cells most likely
through hyperproliferation. UVR-induced activation of the
MAPK signaling pathway in keratinocytes is central to this
surveillance process (Hildesheim et al, 2002). UVR-induced
p38 MAPK signaling ultimately results in activation of
numerous transcription factors, such as p53, c-Myc, and
ATF-2, that promote expression of genes involved in
regulating apoptosis, DNA repair, and cell proliferation
(Bulavin et al, 1999; Cross et al, 2000; Martin-Blanco,
2000; Hildesheim et al, 2002). Contrary to the effectiveness
of these mechanisms under most circumstances, activation
of the stress and proinflammatory cytokine-inducible p38a
and p38b MAPK after acute UVR injury may result in severe
destruction of the skin owing to overwhelming apoptosis,
inflammation, and necrosis among other effects (Afaq and
Mukhtar, 2001; Clydesdale et al, 2001). Keratinocytes are
known to express proinflammatory cytokines after UVR,
such as interleukin-1, interleukin-6, and tumor necrosis
factor-a (Abeyama et al, 2000). Combined, UVR-induced
damage and UVR-induced cytokine expression will in turn
trigger strong p38 MAPK activation. p38 MAPK activation is
required for normal p53 activation and consequent apop-
tosis signaling (Ziegler et al, 1994; Hildesheim et al, 2002).
The additive effects of apoptosis and inflammation will
culminate in epidermal erosion and loss of its barrier
function, which in turn may stimulate keratinocyte hyper-
proliferation to regenerate the damaged epidermis. This
regenerative/hyperproliferative response probably also in-
volves p38 signaling through AP-1 activation (Chen and
Bowden, 2000). Although JNK and ERK MAPK are also
activated by UVR (Kyriakis and Avruch, 1996; Rosette and
Figure 2
Frequency of sunburn cells. Sunburn cells were scored in randomly
selected two 1-cm stretches of skin from UV-irradiated and/or
SB202190-treated skin or unirradiated and/or SB202190-treated skin.
Average counts for all groups were normalized to the counts of
untreated UV-irradiated skin specimens. Average percentages are
depicted. Experiments were conducted in triplicate (three animals per
group) and counts were obtained in a blinded fashion.
Table I. Effect of the p38 MAPK inhibitor SB202190 on UVR-induced sunburn cells
Average sunburn cells/cma
Group With SB202190 Without SB202190 p value (with or without SB202190) b
Control 1.50  0.54 0.66  0.51 0.062
UVR 10.83  2.31 4.16  1.47 0.016
p value (with or without UVR)c 0.015 0.015
aMouse skin was scored for sunburn/apoptotic cells 24 h after irradiation, and a Wilcoxon two-sample test was performed on six independent scores
per group derived from three animals per group.
bThe probabilities (two-sided t approximation) are computed for differences in SB202190-treated versus untreated mice.
cThe probabilities (two-sided t approximation) are computed for differences in UV-irradiated versus unirradiated controls for either SB202190-treated
or untreated mice.
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Karin, 1996; Ip and Davis, 1998), our results clearly indicate
that p38 MAPK is a key factor involved in mediating the
detrimental effects of acute UVR. We have demonstrated
that treating mice with the p38 inhibitor SB202190 is
protective against downstream effects of UVR stress-
induced MAPK activation, namely, apoptosis, inflammation,
and reactive hyperproliferation, which are manifested as
eosinophilic sunburn cells, subcorneal pustules, and epi-
dermal thickening, respectively.
Our results indicate that p38 inhibitors may have
therapeutic value in the treatment of individuals exposed
to cytotoxic doses of DNA-damaging agents. For example,
many important types of stress in addition to UVR, such as
alkylating agents, oxidizing agents, osmotic shock, and
others (Garmyn et al, 2001; Wilhelm et al, 1997; Pandey et
al, 1999; Suh et al, 2000; Suh and Park, 2001; Aggeli et al,
2002; Cheng et al, 2002), trigger a rapid and robust p38
MAPK response, whereas ionizing radiation typically does
not in most cell types (Liu et al, 1996). Based on our results,
Figure 3
Effects of SB202190 on UVR-induced p38 and JNK MAPK activation. Immunohistochemical staining was performed on whole skin of control
mice or UV-irradiated and/or SB202190-treated mice for (A) phosphorylated p38 (p-p38), (B) phosphorylated JNK (p-JNK), (C) p21, and (D)
phosphorylated c-Jun (p-c-Jun). (A) Basal keratinocyte staining (arrowheads) for p-p38 is evident in UV-irradiated skin with (bottom right panel) or
without (bottom left panel) SB202190 treatment. No p-p38 staining is detected in unirradiated control tissues, irrespective of SB202190 treatment
(top panels). (B) p-JNK epidermal staining of both basal and suprabasal keratinocytes (arrowheads) is also detected in UV-irradiated skins
independent of the inhibitor (bottom panels) but absent in unirradiated controls (top panels). (C) Nuclear p21 staining of UV-irradiated skin is only
present in the basal keratinocytes of untreated UV-irradiated skin in accordance with p-p38 localization (bottom left panel). SB202190-treated mice
have virtually no p21 accumulation after UVR (bottom right panel). (D) c-Jun is readily phosphorylated by UVR-activated JNK independently of
SB202190 and is expressed in all epidermal layers, consistent with p-JNK (bottom panels). Images are representative of three animals per group.
Scale bar, 20mm.
Figure4
SB202190 effect on acute UVR-induced inflammation and hyper-
proliferation. Hematoxylin and eosin staining of formalin-fixed skin
shows several features associated with UV irradiation, such as the
presence of sunburn/apoptotic cells with dyskeratotic and vacuolated
cytoplasm and pyknotic nuclei (arrows, panel iii); pronounced epider-
mal thickening resulting from proliferation (panel iii); hyperkeratosis due
to excessive keratin expression (panel iii); and a strong inflammatory
response manifested by the emergence of subcorneal pustules (panel
v). These detrimental effects are dramatically reduced with SB202190
treatment (panels ii and iv). Representative images are shown for
experiments performed on three animals. Scale bar, 20mm.
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treatment with p38 inhibitors, such as SB202190, would be
expected to reduce acute injury responses to a variety of
damaging agents including blistering agents such as
alkylating agents. Acute morbidity could be reduced if
the barrier function of damaged skin was maintained
by reducing apoptosis and consequent inflammatory
responses.
Contrary to its beneficial effects against acute skin
injuries, the detrimental effects of long-term use of p38
inhibitors also need to be considered. The use of these
compounds in the treatment of chronic inflammatory
conditions or even chronic/repeated sun damage, for
instance, may not only compromise the ability of tissues
to monitor the genomic integrity of their cells but also their
ability to eliminate potentially tumorigenic cells (Hildesheim
et al, 2002). Chronic administration of p38 inhibitors may
well have utility in treatment of inflammatory conditions
(Barnes, 2001; Schultz, 2003), but such patients probably
need to reduce exposure to genotoxic agents, such as UVR
and other sources such as cigarette smoke. Chronic
exposure to solar radiation, for instance, is known to induce
mutations in the Tp53 gene. In epidermal keratinocytes,
Tp53 mutations are frequently present in precancerous
lesions and are considered an early event in the progression
to nonmelanoma skin cancers (Ling et al, 2001). In this
scenario, SB202190 treatment may in fact impede the
patients’ ability to eliminate Tp53 mutant epidermal kerati-
nocyte by reducing removal of damaged cells via apoptosis.
Other mutations leading to disruption of tumor suppressors
and/or activation of oncogenes may also arise in severely
damaged cells, which escape the normal p38–p53 surveil-
lance mechanism. Therefore, use of p38 inhibitors should
not be considered ‘‘sunscreen equivalents’’ and careful
monitoring for increased carcinogenic risk may also be
warranted in such patients.
Materials and Methods
Mouse sunburn and terminal deoxynucleotidyl transferase
dUTP nicked end-labeling (TUNEL) assay Adult male C57BL6/
129 mice 6 wk of age were subject to UVB irradiation with
Westinghouse FS20 sunlamp bulbs according to published
procedures (Hildesheim et al, 2002). Briefly, animals were
anesthetized with avertin (2.5%), shaved, and irradiated while
under sedation with 2000 Jm2 UVB. Animals treated with the
SB202190 p38 inhibitor (Calbiochem) were subject to three
intraperitoneal injections of 8 mg SB202190 per kilogram of body
weight at 8-h intervals. The first injection was performed 30 min
before UV irradiation. Twenty-four hours after UVR, full-thickness
skin from irradiated areas was harvested and immediately fixed in
10% neutral-buffered formalin. Fixed tissues were in turn paraffin
embedded and sectioned for hematoxylin and eosin staining.
TUNEL assay was performed with the Dermatacs in situ apoptosis
detection kit (Trevigen) as previously described (Hildesheim et al,
2002).
Immunohistochemistry Five-micrometer-thick sections of forma-
lin-fixed and paraffin-embedded tissues were subject to standard
immunohistochemistry as specified by the manufacturer (Cell
Signaling Technology). Sections were first deparaffinized in xylene
and then rehydrated by sequentially washing them in 100%
ethanol, 95% ethanol, water, and phosphate-buffered saline.
Antigen retrieval was then performed with 10 mM sodium citrate,
pH 6.0, followed by blocking with either 5% goat serum (for
polyclonal antibodies) or 5% horse serum (for monoclonal anti-
body) in phosphate-buffered saline. Next, specimens were
incubated with either anti-p-p38 (1:50), p-SAPK/c-jun N-terminal
kinase (JNK) (1:100), p-c-Jun (1:50) polyclonal antibodies from Cell
Signaling Technology or with anti-p21 (F-5, 1:100) monoclonal
antibody from Santa Cruz Biotechnology. Detection of primary
antibodies was performed with the peroxidase ABC kit as per
manufacturer’s specifications (Vector Laboratories).
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